| Literature DB >> 30716814 |
Abstract
Allergic rhinitis is an immunoglobulin E (IgE)-mediated type I allergic disorder of the nasal mucosa, which is caused by an imbalance in the cytokine network, a number of intracellular signaling pathways being actived. Treg is known to have immunosuppressive effects. Numerous studies have shown that Toll-like receptors play an important immunomodulatory role in the pathogenesis of allergic rhinitis, and TICAM-1, as an important adaptor protein in the Toll-like receptor domain, is involved in signal transduction of allergic rhinitis. This article reviews Treg's impact on the pathogenesis of allergic rhinitis through the TICAM-1 pathway to further understand the role of allergic rhinitis in the pathogenesis and to provide new ideas for therapeutic goals for allergic rhinitis. Copyright© by the Editorial Department of Journal of Clinical Otorhinolaryngology Head and Neck Surgery.Entities:
Keywords: rhinitis, allergic; TICAM-1; Treg
Year: 2018 PMID: 30716814 DOI: 10.13201/j.issn.1001-1781.2018.22.020
Source DB: PubMed Journal: Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi ISSN: 2096-7993